Home » Paradigm, Nanogen, Sangamo File for IPO, Many Others Get Ready

Paradigm, Nanogen, Sangamo File for IPO, Many Others Get Ready

Feb 24, 2000
Premium

W

ASHINGTON--The list of genomics companies planning initial public offerings continues to grow, with Paradigm Genetics, Nanogen, and Sangamo Biosciences about to join the fray. All three have filed IPO registration statements with the Securities and Exchange Commission.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

What's Popular?

In Informatics

  1. Signature Science Wins $2.9M IARPA Contract for Biological Threat Detection Computational Tools

  2. Verge Genomics Forms ALS Research Collaboration

  3. Hearst Invests $75M in M2Gen

  4. Researchers Identify SNP Set, Develop QR Code to Distinguish Genome Samples

  5. Optalysys Readies Optical Sequencing Alignment for Market

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.